Kathy Ackley, Oligonucleotide CMC Consultant
4 December 2022
No Comments
You were Senior Director of Operations and then the Vice President of Development overseeing
Archives: Articles
Procos’ HPAPI unit expansion & future investments
4 December 2022
No Comments
In a continuous evolving world, PROCOS focused the attention on constant investments, and
Peptides and Oligonucleotides, common trends as drugs
4 December 2022
No Comments
Last year in this same forum, we affirmed that we are witnessing a golden age of peptides and oligonucleotides as pharmaceuticals (1)…
Therapeutic oligonucleotides: the promises are up for delivery
2 December 2022
No Comments
Dear reader, This editorial is dedicated to therapeutic oligonucleotides, their existing challenges and how
PREVIEW – CPhI Frankfurt 2022: At the Heart of Pharma
5 October 2022
No Comments
EVENT OVERVIEW CPhI Frankfurt (previously called CPhI Worldwide) – the world’s largest pharma event
PANEL DISCUSSION ON HPAPIs
5 October 2022
No Comments
GENERAL CONSIDERATIONS Innovation has been the driving force of the pharmaceutical industry since its
Enrico Zodio, CEO – Procos
5 October 2022
No Comments
Click HERE to download the PDF We are living in a very intense period:
Giorgio Bertolini, Senior Vice President Olon R&D – Olon
5 October 2022
No Comments
Click HERE to download the PDF Olon is one of the largest European developers
Stefano Togni, Chief Commercial Officer – indena
5 October 2022
No Comments
Click HERE to download the PDF Indena is a full-service provider and partner for
Andrea Taborelli, Business Development and Licensing Manager – IBSA
5 October 2022
No Comments
Click HERE to download the PDF IBSA is a pharmaceutical company with peculiarities that